Tci Wealth Advisors, Inc. Biogen Inc. Transaction History

Tci Wealth Advisors, Inc.

$1.12 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$256.56 - $292.34 $256 - $292	-1 Reduced 0.16%	633 $175,000
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $14,212 - $19,597	-73 Reduced 10.33%	634 $169,000
Q2 2022 Jul 19, 2022	BUY	$187.54 - $223.02 $187 - $223	1 Added 0.14%	707 $144,000
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $2,906 - $3,662	15 Added 2.17%	706 $149,000
Q4 2021 Jan 24, 2022	SELL	$223.92 - $287.77 $27,542 - $35,395	-123 Reduced 15.11%	691 $166,000
Q3 2021 Oct 29, 2021	SELL	$282.99 - $369.05 $82,633 - $107,762	-292 Reduced 26.4%	814 $230,000
Q1 2021 Apr 29, 2021	SELL	$242.95 - $284.63 $12,876 - $15,085	-53 Reduced 4.57%	1,106 $309,000
Q4 2020 Jan 21, 2021	SELL	$236.26 - $355.63 $996,780 - $1.5 Million	-4,219 Reduced 78.45%	1,159 $284,000
Q3 2020 Oct 20, 2020	BUY	$264.77 - $305.71 $794 - $917	3 Added 0.06%	5,378 $1.53 Million
Q1 2020 Apr 14, 2020	SELL	$268.85 - $341.04 $2,688 - $3,410	-10 Reduced 0.19%	5,375 $1.7 Million
Q4 2019 Jan 27, 2020	BUY	$220.06 - $304.07 $2,200 - $3,040	10 Added 0.19%	5,385 $1.6 Million
Q3 2019 Oct 17, 2019	SELL	$217.44 - $243.88 $69,580 - $78,041	-320 Reduced 5.62%	5,375 $1.25 Million
Q2 2019 Jul 23, 2019	SELL	$219.29 - $241.72 $116,223 - $128,111	-530 Reduced 8.51%	5,695 $1.33 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $27,883 - $36,463	-95 Reduced 1.5%	6,225 $2.2 Million
Q4 2017 Feb 01, 2018	SELL	$307.64 - $344.58 $39,377 - $44,106	-128 Reduced 1.99%	6,320 $2.01 Million
Q3 2017 Oct 24, 2017	SELL	$281.15 - $329.69 $843 - $989	-3 Reduced 0.05%	6,448 $2.02 Million
Q2 2017 Aug 10, 2017	BUY	N/A	6,451	6,451 $1.75 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.

Account